Skip to content

3 Fixation Devices in Laparoscopic Ventral Herniotomy

A Controlled Randomized Study of Protack, Securestrap and Glubran Glue as Fixation Devices in Laparoscopic Ventral Herniotomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01534780
Acronym
FS
Enrollment
75
Registered
2012-02-17
Start date
2013-04-30
Completion date
2017-08-31
Last updated
2020-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventral Hernia

Brief summary

Clinical, controlled, randomized, prospective study. Ventral hernias between 2(1.5)cm and 7 cm, laparoscopic surgery with intraperitoneal onlay mesh. Three randomization groups of 25 patients giving a total of 75 patients. Mesh is fixated with either Protack, Securestrap or Glubran II. Primary outcome: postoperative pain on the 2nd postoperative day. Secondary outcomes: pain, quality of life, recurrence and adhesions at 1, 6, 12, 24, 36, 48 and 60 months postoperative.

Detailed description

see brief summary

Interventions

PROCEDURElaparoscopic ventral herniotomy

Laparoscopy in general anesthesia are performed with placement of Physiomesh intraperitoneally. Fixation of the mesh is performed with 1 of 3 possible devices

DEVICEProtack

fixation of mesh with protack

DEVICESecurestrap

fixation of mesh with Securestrap

DEVICEGlubran

fixation of mesh with Glubran

Sponsors

Randers Regional Hospital
CollaboratorOTHER
Horsens Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* ventral hernia 2(1,5) \< dia \> 7 cm * danish speaking * of sound mind * bmi \< 35 * ASA 3 or less, no contra indication against laparoscopy

Exclusion criteria

* other size hernias, * no danish, * bmi \> 35

Design outcomes

Primary

MeasureTime frameDescription
Pain1 measurement, 2nd postoperative dayDolo Test (VAS)

Secondary

MeasureTime frameDescription
hernia recurrence7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60clinical examination and perhaps CT scan
quality of life7 measurements, postoperative month 1, 6, 12, 24, 36, 48 and 60SF 36 and Carolina's Comfort Scale
Pain7 measurements, day 1, 3 and 4 and postoperative month 1, 6, 12, 24Dolo Test(VAS)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026